US Stock MarketDetailed Quotes

Telomir Pharmaceuticals (TELO)

Watchlist
  • 1.370
  • +0.020+1.48%
Close Jan 15 16:00 ET
  • 1.380
  • +0.010+0.73%
Post 18:23 ET
47.10MMarket Cap-4.11P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Telomir Pharmaceuticals (TELO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-80.91%1.15M
243.84%5.07M
14.18%2.19M
210.55%12.24M
169.36%2.91M
529.48%6.01M
3.38%1.47M
296.75%1.92M
361.52%3.94M
121.44%1.08M
Selling and administrative expenses
-92.81%386.95K
471.46%5.03M
149.59%1.85M
1,505.54%9.64M
566.94%2.64M
5,163.42%5.38M
1,363.55%879.7K
1,640.58%741.54K
2,766.11%600.19K
3,937.28%395.29K
-General and administrative expense
-92.81%386.95K
471.46%5.03M
149.59%1.85M
1,505.54%9.64M
566.94%2.64M
5,163.42%5.38M
1,363.55%879.7K
1,640.58%741.54K
2,766.11%600.19K
3,937.28%395.29K
Research and development costs
21.05%759.53K
-92.80%42.84K
-58.09%337K
41.99%2.24M
32.04%269.08K
138.97%627.43K
-10.91%594.8K
82.59%804.02K
88.95%1.57M
-57.31%203.78K
Other operating expenses
----
----
----
-79.04%370.5K
--0
----
----
--370.5K
--1.77M
--479.55K
Operating profit
80.91%-1.15M
-243.84%-5.07M
-14.18%-2.19M
-210.55%-12.24M
-169.36%-2.91M
-529.48%-6.01M
-3.38%-1.47M
-296.75%-1.92M
-361.52%-3.94M
-121.44%-1.08M
Net non-operating interest income expense
186.06%44.18K
-99.92%20
100.18%7.95K
-161.13%-4.29M
100.93%7.06K
102.04%15.45K
120.55%25.49K
-4.34M
-1.64M
-761.82K
Non-operating interest income
186.06%44.18K
-94.66%1.36K
----
--48K
--7.06K
--15.45K
--25.49K
----
--0
--0
Non-operating interest expense
--0
--1.34K
----
164.05%4.34M
-100.00%-1
--0
--0
--4.34M
--1.64M
--761.82K
Total other finance cost
----
----
-100.18%-7.95K
----
----
----
----
--4.34M
----
----
Other net income (expense)
-7.49M
Special income (charges)
----
----
----
--0
----
----
----
----
---7.49M
----
-Less:Other special charges
----
----
----
----
----
----
----
----
--7.49M
----
Income before tax
81.60%-1.1M
-249.89%-5.07M
65.15%-2.18M
-26.48%-16.53M
68.93%-2.9M
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
Income tax
Net income
81.60%-1.1M
-249.89%-5.07M
65.15%-2.18M
-26.48%-16.53M
68.93%-2.9M
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
Net income continuous Operations
81.60%-1.1M
-249.89%-5.07M
65.15%-2.18M
-26.48%-16.53M
68.93%-2.9M
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
Minority interest income
Net income attributable to the parent company
81.60%-1.1M
-249.89%-5.07M
65.15%-2.18M
-26.48%-16.53M
68.93%-2.9M
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
81.60%-1.1M
-249.89%-5.07M
65.15%-2.18M
-26.48%-16.53M
68.93%-2.9M
-250.06%-5.99M
6.54%-1.45M
-1,195.12%-6.25M
-1,430.40%-13.07M
-1,814.86%-9.33M
Basic earnings per share
85.00%-0.03
-240.00%-0.17
69.57%-0.07
-26.85%-0.56
68.25%-0.1
-246.04%-0.2
4.51%-0.05
-1,310.18%-0.23
-1,430.39%-0.4415
-1,814.92%-0.315
Diluted earnings per share
85.00%-0.03
-240.00%-0.17
69.57%-0.07
-26.85%-0.56
68.25%-0.1
-246.04%-0.2
4.51%-0.05
-1,310.18%-0.23
-1,430.39%-0.4415
-1,814.92%-0.315
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -80.91%1.15M243.84%5.07M14.18%2.19M210.55%12.24M169.36%2.91M529.48%6.01M3.38%1.47M296.75%1.92M361.52%3.94M121.44%1.08M
Selling and administrative expenses -92.81%386.95K471.46%5.03M149.59%1.85M1,505.54%9.64M566.94%2.64M5,163.42%5.38M1,363.55%879.7K1,640.58%741.54K2,766.11%600.19K3,937.28%395.29K
-General and administrative expense -92.81%386.95K471.46%5.03M149.59%1.85M1,505.54%9.64M566.94%2.64M5,163.42%5.38M1,363.55%879.7K1,640.58%741.54K2,766.11%600.19K3,937.28%395.29K
Research and development costs 21.05%759.53K-92.80%42.84K-58.09%337K41.99%2.24M32.04%269.08K138.97%627.43K-10.91%594.8K82.59%804.02K88.95%1.57M-57.31%203.78K
Other operating expenses -------------79.04%370.5K--0----------370.5K--1.77M--479.55K
Operating profit 80.91%-1.15M-243.84%-5.07M-14.18%-2.19M-210.55%-12.24M-169.36%-2.91M-529.48%-6.01M-3.38%-1.47M-296.75%-1.92M-361.52%-3.94M-121.44%-1.08M
Net non-operating interest income expense 186.06%44.18K-99.92%20100.18%7.95K-161.13%-4.29M100.93%7.06K102.04%15.45K120.55%25.49K-4.34M-1.64M-761.82K
Non-operating interest income 186.06%44.18K-94.66%1.36K------48K--7.06K--15.45K--25.49K------0--0
Non-operating interest expense --0--1.34K----164.05%4.34M-100.00%-1--0--0--4.34M--1.64M--761.82K
Total other finance cost ---------100.18%-7.95K------------------4.34M--------
Other net income (expense) -7.49M
Special income (charges) --------------0-------------------7.49M----
-Less:Other special charges ----------------------------------7.49M----
Income before tax 81.60%-1.1M-249.89%-5.07M65.15%-2.18M-26.48%-16.53M68.93%-2.9M-250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M
Income tax
Net income 81.60%-1.1M-249.89%-5.07M65.15%-2.18M-26.48%-16.53M68.93%-2.9M-250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M
Net income continuous Operations 81.60%-1.1M-249.89%-5.07M65.15%-2.18M-26.48%-16.53M68.93%-2.9M-250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M
Minority interest income
Net income attributable to the parent company 81.60%-1.1M-249.89%-5.07M65.15%-2.18M-26.48%-16.53M68.93%-2.9M-250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 81.60%-1.1M-249.89%-5.07M65.15%-2.18M-26.48%-16.53M68.93%-2.9M-250.06%-5.99M6.54%-1.45M-1,195.12%-6.25M-1,430.40%-13.07M-1,814.86%-9.33M
Basic earnings per share 85.00%-0.03-240.00%-0.1769.57%-0.07-26.85%-0.5668.25%-0.1-246.04%-0.24.51%-0.05-1,310.18%-0.23-1,430.39%-0.4415-1,814.92%-0.315
Diluted earnings per share 85.00%-0.03-240.00%-0.1769.57%-0.07-26.85%-0.5668.25%-0.1-246.04%-0.24.51%-0.05-1,310.18%-0.23-1,430.39%-0.4415-1,814.92%-0.315
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -